We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Skinbiotherapeutics Plc | LSE:SBTX | London | Ordinary Share | GB00BF33H870 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.025 | 0.14% | 17.375 | 17.25 | 17.50 | 17.375 | 17.25 | 17.25 | 180,461 | 08:26:09 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 132k | -2.84M | -0.0125 | -13.90 | 39.23M |
Date | Subject | Author | Discuss |
---|---|---|---|
11/12/2024 12:44 | OPTI maker sems to have a template deviation actually for them. It's always within 2% on SP Anyway, worked this one out.And know what it is Big falls from next week if not sooner | putinaire | |
11/12/2024 12:43 | Not so: Ashman says Macquarie are out a while back. So OPTI still the prime suspect. | pr100 | |
11/12/2024 12:42 | Everyone knows what the maker at opti does to appease the sellers. Thst's near it's point now. A constasnt norm in all spikes including past July's etc Question is, what is maker norm here>? | putinaire | |
11/12/2024 12:32 | Was there news? Or the maker supporting it? haha Big divergence week. Be careful. Shorters back next week | putinaire | |
11/12/2024 10:26 | O'Hara says he has just about finished selling. I think Macquarie are the big seller as they acquired 21m shares earlier this year in the CLN fiasco and even if they shift 30% of them onto willing buyers, that still leaves them with over 13m shares to dump (at over 100% profit). | pr100 | |
11/12/2024 09:45 | 16.50 v 17p +0.75p That's the way, the way I like it | master rsi | |
11/12/2024 09:31 | 16.25 v 16.50p Moving up in the right direction Time to go where it should be | master rsi |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions